These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1825107

  • 1. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone.
    Alegre ML, Vandenabeele P, Depierreux M, Florquin S, Deschodt-Lanckman M, Flamand V, Moser M, Leo O, Urbain J, Fiers W.
    J Immunol; 1991 Feb 15; 146(4):1184-91. PubMed ID: 1825107
    [Abstract] [Full Text] [Related]

  • 2. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V, Flament V, Gérard C, Abramowicz D, Vandenabeele P, Wissing M, Delvaux A, Fiers W, Leo O, Velu T.
    Transplantation; 1994 May 27; 57(10):1436-9. PubMed ID: 8197603
    [Abstract] [Full Text] [Related]

  • 3. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.
    Alegre M, Vandenabeele P, Flamand V, Moser M, Leo O, Abramowicz D, Urbain J, Fiers W, Goldman M.
    Eur J Immunol; 1990 Mar 27; 20(3):707-10. PubMed ID: 2138564
    [Abstract] [Full Text] [Related]

  • 4. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.
    Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, Bluestone J, Bach JF.
    Eur J Immunol; 1990 Mar 27; 20(3):509-15. PubMed ID: 2138557
    [Abstract] [Full Text] [Related]

  • 5. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML, Tso JY, Sattar HA, Smith J, Desalle F, Cole M, Bluestone JA.
    J Immunol; 1995 Aug 01; 155(3):1544-55. PubMed ID: 7636216
    [Abstract] [Full Text] [Related]

  • 6. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
    Alegre ML, Collins AM, Pulito VL, Brosius RA, Olson WC, Zivin RA, Knowles R, Thistlethwaite JR, Jolliffe LK, Bluestone JA.
    J Immunol; 1992 Jun 01; 148(11):3461-8. PubMed ID: 1534096
    [Abstract] [Full Text] [Related]

  • 7. Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome.
    Alegre ML, Gastaldello K, Abramowicz D, Kinnaert P, Vereerstraeten P, De Pauw L, Vandenabeele P, Moser M, Leo O, Goldman M.
    Transplantation; 1991 Oct 01; 52(4):674-9. PubMed ID: 1833865
    [Abstract] [Full Text] [Related]

  • 8. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J, Davis J, Bracht M, Carton J, Armstrong J, Gao W, Scallon B, Fung R, Emmell E, Zimmerman M, Griswold DE, Li L.
    Int Immunopharmacol; 2006 Jun 01; 6(6):880-91. PubMed ID: 16644473
    [Abstract] [Full Text] [Related]

  • 9. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
    Bemelmans MH, Abramowicz D, Gouma DJ, Goldman M, Buurman WA.
    J Immunol; 1994 Jul 15; 153(2):499-506. PubMed ID: 8021491
    [Abstract] [Full Text] [Related]

  • 10. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 11. Temperature requirements and kinetics of T cell signaling. Velocity of triggering correlates with functional effects of anti-CD3 mAb.
    Abdi K, Reed ML, Mentzer SJ, Herrmann SH.
    J Immunol; 1989 May 01; 142(9):2971-80. PubMed ID: 2468707
    [Abstract] [Full Text] [Related]

  • 12. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.
    Hirsch R, Eckhaus M, Auchincloss H, Sachs DH, Bluestone JA.
    J Immunol; 1988 Jun 01; 140(11):3766-72. PubMed ID: 3286764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of neonatal injections of anti-CD3 epsilon monoclonal antibodies on the T cell functions of adult mice.
    Rueff-Juy D, Drapier AM, Cazenave PA.
    J Immunol; 1989 Jun 01; 142(11):3788-95. PubMed ID: 2523935
    [Abstract] [Full Text] [Related]

  • 15. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR, Taylor PA, Vallera DA.
    J Immunol; 1994 Apr 01; 152(7):3665-74. PubMed ID: 8144942
    [Abstract] [Full Text] [Related]

  • 16. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
    Vossen AC, Tibbe GJ, Kroos MJ, van de Winkel JG, Benner R, Savelkoul HF.
    Eur J Immunol; 1995 Jun 01; 25(6):1492-6. PubMed ID: 7614975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA.
    J Immunol; 1989 Feb 01; 142(3):737-43. PubMed ID: 2521507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.